REFERENCES
- Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease, 7th ed. Philadelphia: Elsevier Saunders; 2005.
- Kiss S, et al. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005; 112(6): 1066–1071.
- Basic-Jukic N, et al. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation? Transplant Proc. 2005; 37(2): 850–851.
- Moreso F, et al. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses. Clin Transplant. 1998; 12(3): 198–205.
- Sarmiento JM, et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant. 2000; 14(2): 136–138.
- Woywodt A, et al. Cytomegalovirus colitis during mycophenolate mofetil therapy for Wegener’s granulomatosis. Am J Nephrol. 2000; 20(6): 468–472.
- Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000; 47(2-3): 85–118.